Liquidia Corporation Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
LQDA Company Description
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
LQDA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view LQDA Smart Score
Score Breakdown
LQDA Company Description
Show More
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of LQDA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LQDA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on LQDA's company Twitter account
WallStreetBets
Number of mentions of LQDA in WallStreetBets Daily Discussion
LQDA News
Recent insights relating to LQDA
CNBC Recommendations
Recent picks made for LQDA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in LQDA
Corporate Flights
Flights by private jets registered to LQDA
Our Analysis